Literature DB >> 9270500

Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions.

P Rudolph1, C Schubert, B Schubert, R Parwaresch.   

Abstract

BACKGROUND: A discrimination between benign and malignant melanocytic lesions is not always possible by conventional histology.
OBJECTIVE: Our purpose was to determine the proliferative activity in various types of melanocytic neoplasms and to appraise its value as a diagnostic adjunct.
METHODS: The growth fraction was assessed immunohistochemically in 398 melanocytic lesions by means of the monoclonal antibody Ki-S5 directed to the Ki-67 antigen. In this way, a cut-off level was defined and applied to 112 lesions of equivocal histology. The revised diagnoses were correlated to the clinical courses.
RESULTS: Common nevi, Spitz nevi, and melanomas exhibited significantly different proliferation indices and distinctive distribution patterns of cycling cells. In agreement, malignancy diagnosed on the basis of a growth fraction greater than 5% was confirmed by disease progression in 68% of our cases with uncertain diagnosis.
CONCLUSION: Determination of the proliferative activity in melanocytic lesions may usefully complement conventional histology to improve diagnostic accuracy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270500     DOI: 10.1016/s0190-9622(97)80121-1

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology.

Authors:  Kenneth G Linden; Sancy A Leachman; Jonathan S Zager; James G Jakowatz; Jaye L Viner; Christine E McLaren; Ronald J Barr; Philip M Carpenter; Wen-Pin Chen; Craig A Elmets; Joseph A Tangrea; Sung-Jig Lim; Alistair J Cochran; Frank L Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2014-03-10

2.  Telomerase activity in melanocytic lesions: A potential marker of tumor biology.

Authors:  P Rudolph; C Schubert; S Tamm; K Heidorn; A Hauschild; I Michalska; S Majewski; G Krupp; S Jablonska; R Parwaresch
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 3.  From melanocytes to melanomas.

Authors:  A Hunter Shain; Boris C Bastian
Journal:  Nat Rev Cancer       Date:  2016-04-29       Impact factor: 60.716

Review 4.  Melanocytic nevi simulant of melanoma with medicolegal relevance.

Authors:  Guido Massi
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.